Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bentué-Ferrer

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
European Neurology|March 27, 1998
Clinical efficacy of almitrine-raubasine. An overviewH Allain, D Bentué-Ferrer
Presse Medicale (Paris, France : 1983)|June 7, 1997
[Parkinson disease: interrogations and solutions]H Allain, D Bentué-Ferrer
Presse Medicale (Paris, France : 1983)|May 3, 2002
[Effect of almitrine/raubasine on cerebral metabolism in the elderly]H Allain, D Bentué-Ferrer
Clinical Therapeutics|July 1, 1990
Choosing a target for cognitive enhancersH Allain, D Bentué-Ferrer, R Decombe
Revue Neurologique|June 15, 1999
[Beta interferon in multiple sclerosis: pharmacological differences]H Allain, D Bentué-Ferrer, S Schück, et al.
Experimental Brain Research|January 1, 1994
Temporal profile of aminergic neurotransmitter release in striatal dialysates in rats with post-ischemic seizuresD Bentué-Ferrer, E Bellissant, R Decombe, et al.
L'Encephale|August 7, 2007
[Prescription of olanzapine in children and adolescent psychiatric patients]T Frémaux, J-M Reymann, C Chevreuil, et al.
Therapie|November 1, 1993
[Calcium antagonists and the central nervous system]H Allain, D Bentué-Ferrer, B Saiag, et al.
Revue Neurologique|March 24, 2004
[Myoclonic encephalopathy associated with proton pump inhibitors]J Boulliat, E Polard, F Colin, et al.
La Revue De Medecine Interne|May 1, 1988
[Pharmacology of central cholinergic synapse]R Decombe, D Bentué-Ferrer, J Van den Driessche, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
European Neurology|March 27, 1998
Clinical efficacy of almitrine-raubasine. An overviewH Allain, D Bentué-Ferrer
Presse Medicale (Paris, France : 1983)|June 7, 1997
[Parkinson disease: interrogations and solutions]H Allain, D Bentué-Ferrer
Presse Medicale (Paris, France : 1983)|May 3, 2002
[Effect of almitrine/raubasine on cerebral metabolism in the elderly]H Allain, D Bentué-Ferrer
Clinical Therapeutics|July 1, 1990
Choosing a target for cognitive enhancersH Allain, D Bentué-Ferrer, R Decombe
Revue Neurologique|June 15, 1999
[Beta interferon in multiple sclerosis: pharmacological differences]H Allain, D Bentué-Ferrer, S Schück, et al.
Experimental Brain Research|January 1, 1994
Temporal profile of aminergic neurotransmitter release in striatal dialysates in rats with post-ischemic seizuresD Bentué-Ferrer, E Bellissant, R Decombe, et al.
L'Encephale|August 7, 2007
[Prescription of olanzapine in children and adolescent psychiatric patients]T Frémaux, J-M Reymann, C Chevreuil, et al.
Therapie|November 1, 1993
[Calcium antagonists and the central nervous system]H Allain, D Bentué-Ferrer, B Saiag, et al.
Revue Neurologique|March 24, 2004
[Myoclonic encephalopathy associated with proton pump inhibitors]J Boulliat, E Polard, F Colin, et al.
La Revue De Medecine Interne|May 1, 1988
[Pharmacology of central cholinergic synapse]R Decombe, D Bentué-Ferrer, J Van den Driessche, et al.
Pageof 5